[ad_1]
(MedPage Today) — SAN DIEGO — Tezepelumab (Tezspire) reduced nasal polyps and symptoms in severe chronic rhinosinusitis while also decreasing need for further treatments, the WAYPOINT trial showed.
The monoclonal antibody against thymic stromal…
[ad_2]
Source link : https://www.medpagetoday.com/meetingcoverage/aaaai/114448
Author :
Publish date : 2025-03-02 15:53:20
Copyright for syndicated content belongs to the linked Source.
Tezspire Treats Chronic Sinus Symptoms With Nasal Polyps